A generic pharmaceutical manufacturer, Glenmark Pharmaceuticals Inc. USA (Glenmark), located in Mahwah, New Jersey, has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug. Read More
Home » Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
Related Posts
Owner of California Blood Testing Laboratory Pleads Guilty to Tax and
A California man pleaded guilty to tax and health care related crimes. Read More
Four Hawaii Individuals Convicted of Tax Refund Fraud Scheme
A federal jury convicted four individuals from Hawaii for their roles in a tax refund fraud scheme. Read More